Author

L. Steffens Reinhardt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. K. Enjeti· 1 shared A. Mannan· 1 shared B. M. Harvey· 1 shared C. de Bock· 1 shared C. Lawlor-O'Neill· 1 shared C. Riveros· 1 shared D. R. Bond· 1 shared E. A. Roper· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Enjeti

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for AML cell self-renewal.

D. R. Bond, S. M. Burnard, K. Uddipto, K. V. Hunt, B. M. Harvey, L. Steffens Reinhardt, C. Lawlor-O'Neill, E. A. Roper, S. Humphries, H. C. Murray, A. Mannan, M. D. Dun, C. de Bock, N. A. Bowden, A. K. Enjeti, , H. J. Lee

This study shows that hypomethylating agents induce epigenetic and transcriptional heterogeneity in AML cells, with some cells retaining methylation and showing increased self-renewal, and identifies statins as a potential co-treatment to enhance HMA efficacy.

bioRxiv · Jan 30, 2024Cancer Biology